• News
  • SAN DIEGO
  • Medical

Illumina makes inroads into Europe

San Diego’s Illumina Inc. (Nasdaq: ILMN) has entered into a series of separate agreements for its non-invasive pre-natal testing products to be used in Europe. Illumina’s tests will be used by the Center for Human Genetics and Laboratory Diagnostics in Germany, the Genoma Group in Italy and Biomnis Laboratories in France.

“Biomnis evaluated the different technologies and selected Illumina because of their high level of performance as published in respected, peer-reviewed medical journals,” said Biomnis CEO Charles Woler.

In morning trading on Monday, Illumina stock rose more than 3.7 percent. The stock analysis firm Trade-Ideas LLC identified Illumina (ILMN) as a “momo momentum candidate” for its recent stock rises.

User Response
0 UserComments

Illumina Inc.

Company Website

9885 Towne Centre Dr.
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ILMN
150.22
  -1.62  
- 1.07%
1,601,217,000
242.37
130.0

Insider Trade Data

Date Insider Shares Type Value
10/15/2015 Flatley, Jay T 10,000 Sell $1,500,000
10/15/2015 Flatley, Jay T 10,000 Exchange $279,700
10/15/2015 Flatley, Jay T 10,000 Sell $1,500,000
10/07/2015 Bradbury, Daniel M 1,700 Sell $247,878
10/07/2015 Bradbury, Daniel M 1,700 Exchange $75,667

Illumina Inc. Executive(s):

Jay Flatley

  • Chief Executive Officer, President

Similar Companies

NAICS - 334516 - Analytical Laboratory Instrument Manufacturing
NAICS - 541711 - Research and Development in Biotechnology